In a new draft guidance issued on January 14, 2026, the FDA discussed the use of a modern statistical methodology in clinical trials designed to ...
If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...
Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...
The US Food and Drug Administration (FDA) is now “open to bayesian statistics,” contrasting this with the frequentist approach that the agency and the drug industry have historically relied on for ...
Disrupting left superior frontal sulcus selectively impaired perceptual but not value-based decisions, revealing segregated ...
Trial-to-trial variability can result from both deterministic sources, such as complex dynamics or internal states, and randomness — that is, noise. This Review focuses on noise and its impact along ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. When Emmanuel Macron ran for re-election in 2022, he did what few French politicians dare to do: tell voters ...
Discover how sample size neglect impacts statistical conclusions and learn to avoid this cognitive bias studied by renowned experts like Tversky and Kahneman.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results